Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies...
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage
About this item
Full title
Author / Creator
Bousiges, Olivier , Bombois, Stephanie , Schraen, Susanna , Wallon, David , Quillard, Muriel Muraine , Gabelle, Audrey , Lehmann, Sylvain , Paquet, Claire , Amar-Bouaziz, Elodie , Magnin, Eloi , Miguet-Alfonsi, Carole , Delbeuck, Xavier , Lavaux, Thomas , Anthony, Pierre , Philippi, Nathalie , Blanc, Frederic and ePLM network and collaborators
Publisher
England: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundDifferential diagnosis between dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD) is not straightforward, especially in the early stages of disease. We compared AD biomarkers (phospho-Tau181, total-Tau, Aβ42 and Aβ40) in cerebrospinal fluid (CSF) of patients with DLB and AD, focusing especially on the prodromal stage.MethodsA to...
Alternative Titles
Full title
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage
Authors, Artists and Contributors
Author / Creator
Bombois, Stephanie
Schraen, Susanna
Wallon, David
Quillard, Muriel Muraine
Gabelle, Audrey
Lehmann, Sylvain
Paquet, Claire
Amar-Bouaziz, Elodie
Magnin, Eloi
Miguet-Alfonsi, Carole
Delbeuck, Xavier
Lavaux, Thomas
Anthony, Pierre
Philippi, Nathalie
Blanc, Frederic
ePLM network and collaborators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_01842303v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_01842303v1
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/jnnp-2017-316385
